NCT00536978
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +20 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
2,774 public trials
698 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT02590263
- Conditions
- Astrocytoma, Glioblastoma, Glioblastoma Multiforme, +17 more
- Locations
-
- Nagoya University Hospital /ID# 138559 Nagoya, Aichi-ken, Japan
- Hiroshima University Hospital /ID# 139399 Hiroshima, Japan
- Hokkaido University Hospital /ID# 150589 Sapporo, Hokkaido, Japan
- University of Tsukuba Hospital /ID# 140433 Tsukuba, Ibaraki, Japan
NCT03097770
- Conditions
- Adult Acute Lymphoblastic Leukemia in Remission, B-cell Adult Acute Lymphoblastic Leukemia, B-cell Chronic Lymphocytic Leukemia, +45 more
- Locations
-
- Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital Beijing, Beijing Municipality, China
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Beijing cancer hospital Beijing, Beijing Municipality, China
- Peking University third hospital Beijing, Beijing Municipality, China
- The 307th Hospital of Military Medical Sciences Beijing, Beijing Municipality, China
- Harbin Medical University Cancer Hospital Haerbin, Heilongjiang, China
Completed
To Decrease Fatigue With Light Therapy
NCT03242902
- Conditions
- Diffuse Large B Cell Lymphoma, Dyssomnias, Hemic and Lymphatic Diseases, +17 more
- Locations
-
- Radboudumc Nijmegen, Gelderland, Netherlands
- Netherlands Cancer Institute Amsterdam, North Holland, Netherlands
- VUmc Amsterdam, North Holland, Netherlands
- Leids Universitair Medisch Centrum Leiden, South Holland, Netherlands
NCT02343536
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
- University of Chicago Chicago, Illinois, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana Farber Cancer Institute Boston, Massachusetts, United States
Completed
A Pilot Study of Sorafenib Examining Biomarkers in Refractory or Relapsed T-Cell Lymphoma Patients
NCT01561833
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
NCT02867566
- Conditions
- Diffuse, Large B-Cell, Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Institute of Hematology; Chinese Academy of Medical Sciences Tianjin, China
NCT00981097
- Conditions
- Blood-Borne Infections, Burkitt Lymphoma, Communicable Diseases, +29 more
- Locations
-
- Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
- UCLA Clinical AIDS Research and Education (CARE) Center Los Angeles, California, United States
- University of California at Davis Center for Aids Research and Education Services Sacramento, California, United States
- UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
NCT00436280
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Créteil, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Dijon, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lille, France
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Nice, France